"Assessing the Impact of Prakriti-Based Variations on Asthikshaya Severity and the Benefits of Ashwagandha Powder Compared to Vitamin D3 and Calcium in Treating Postmenopausal Asthikshaya: A Clinical Trial"

Evaluation of Prakriti based variation in severity of Asthikshaya and Add on efficacy of Ashwagandha Churna [Withania somnifera Dunal.] over vitamin D3 and calcium supplementation in management of Postmenopausal Asthikshaya: An Open-label Randomized Clinical Trial. - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076266

Enrollment

Registered

2024-11-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 7- Osteopathic

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having asthikshaya score greater than 15 will be enrolled in the study. BMD score between -1 to -2.5 (osteopenia) as obtain from DEXA Scan. Patient willing to give written informed consent.

Exclusion criteria

Exclusion criteria: Patient having any trauma & bone injury. Patient having any systematic disease not relevant to the study. Patient with uncontrolled hypertension, DM chronic severe respiratory disease.

Design outcomes

Primary

Measure	Time frame
1. Changes in BMD Score as assessed by Dual-energy X-ray absorptiometry (DEXA scan) (Baseline vs 90th day). 2.Improvement in Asthikshya score as assessed by Asthikshya Questionnaire (baseline vs 90th day). Timepoint: baseline 90th day	—

Secondary

Measure	Time frame
1. Improvement in Osteoporosis-related quality of life scores as assessed by QUALEFFO-41 questionnaire (Baseline vs 90th day).Timepoint: Baseline 90 days	—

Countries

India

Contacts

Public ContactDR LAXMI MAHARANA

All india institute of ayurveda delhi

laxmimaharana01@gmail.com8851063951

Outcome results